Chiome Bioscience Inc.
4583.T · JPX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | ¥15,658 | ¥6,689 | ¥7,829 | ¥7,854 |
| - Cash | ¥2,063 | ¥1,326 | ¥1,727 | ¥1,791 |
| + Debt | ¥282 | ¥291 | ¥184 | ¥183 |
| Enterprise Value | ¥13,876 | ¥5,654 | ¥6,286 | ¥6,246 |
| Revenue | ¥781 | ¥682 | ¥631 | ¥713 |
| % Growth | 14.4% | 8.2% | -11.5% | – |
| Gross Profit | ¥433 | ¥399 | ¥349 | ¥422 |
| % Margin | 55.4% | 58.4% | 55.3% | 59.3% |
| EBITDA | -¥1,014 | -¥1,212 | -¥1,235 | -¥1,462 |
| % Margin | -129.8% | -177.6% | -195.8% | -205.1% |
| Net Income | -¥1,021 | -¥1,220 | -¥1,243 | -¥1,480 |
| % Margin | -130.7% | -178.8% | -197% | -207.6% |
| EPS Diluted | -17.54 | -24.62 | -28.26 | -36.74 |
| % Growth | 28.8% | 12.9% | 23.1% | – |
| Operating Cash Flow | -¥1,001 | -¥1,069 | -¥1,191 | -¥1,131 |
| Capital Expenditures | ¥0 | ¥0 | ¥0 | ¥0 |
| Free Cash Flow | -¥1,001 | -¥1,069 | -¥1,191 | -¥1,131 |